21 CFR Part 201 - PART 201—LABELING
- Subpart A—General Labeling Provisions (§§ 201.1 - 201.26)
- Subpart B—Labeling Requirements for Prescription Drugs and/or Insulin (§§ 201.50 - 201.58)
- Subpart C—Labeling Requirements for Over-the-Counter Drugs (§§ 201.60 - 201.80)
- Subpart D—Exemptions From Adequate Directions for Use (§§ 201.100 - 201.129)
- Subpart E—Other Exemptions (§§ 201.150 - 201.161)
- Subpart F—Labeling Claims for Drugs in Drug Efficacy Study (§ 201.200)
- Subpart G—Specific Labeling Requirements for Specific Drug Products (§§ 201.300 - 201.328)
- Appendix A to Part 201—Examples of Graphic Enhancements Used by FDA
Authority:
Source:
40 FR 13998, Mar. 27, 1975, unless otherwise noted.
Editorial Note:
Nomenclature changes to part 201 appear at 69 FR 13717, Mar. 24, 2004.